Bayesian Capital Management’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-28,700
Closed -$618K 426
2025
Q3
$618K Buy
+28,700
New +$652K 0.13% 242
2023
Q4
Sell
-20,596
Closed -$701K 972
2023
Q3
$701K Buy
20,596
+11,796
+134% +$445K 0.08% 288
2023
Q2
$346K Sell
8,800
-43,500
-83% -$1.57M 0.04% 500
2023
Q1
$1.68M Buy
52,300
+34,400
+192% +$1.14M 0.21% 142
2022
Q4
$558K Buy
17,900
+9,200
+106% +$333K 0.08% 321
2022
Q3
$322K Buy
+8,700
New +$326K 0.07% 397

Other funds holding PGNY

Bayesian Capital Management's PGNY Position: Q4 2025 in Review

Bayesian Capital Management sold out of Progyny (PGNY) in Q4 2025, closing a stake of 28,700 shares — an estimated $618K sold.

Bayesian Capital Management first reported a position in PGNY in Q3 2022 and held it in 6 quarters. The position peaked at $1.68M in Q1 2023. 313 funds tracked by Wall St. Rank hold PGNY as of Q4 2025.

  • Bayesian Capital Management reported no remaining Progyny position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 28,700 Progyny shares in Q4 2025, an estimated $618K.
  • Bayesian Capital Management first reported a position in Progyny in Q3 2022 and held it in 6 quarters.
  • Bayesian Capital Management's Progyny position peaked at $1.68M in Q1 2023.
  • 313 funds tracked by Wall St. Rank held Progyny as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.